Comparing Two Acid Reflux Medicines for Erosive Esophagitis
Treatments studied
Part of Digestive system clinical trials.
This study compares two medications, vonoprazan and esomeprazole, to see which works better for healing damage to the esophagus caused by acid reflux (erosive esophagitis). If you have this condition, this trial could help find you the most effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have been diagnosed with erosive esophagitis (a type of esophagus damage from acid reflux) through an endoscopy (a camera test).
- Your GERD-Q score (a questionnaire about reflux symptoms) is 8.
- You are willing to follow the treatment plan in this study.
- You do not have other stomach or esophagus conditions like ulcers, cancer, or infections (H. pylori).
- You have not had surgery on your esophagus or stomach, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This study compares two medications—vonoprazan and esomeprazole—to see which one heals acid reflux-related damage in the esophagus better after POEM surgery for achalasia. If you have had POEM and now have heartburn and moderate to severe esophagitis, this trial may help find the best treatment for you.
This trial compares two types of acid-reducing medicines to see which is better at preventing re-bleeding in people who have had severe ulcer bleeding. If you qualify, you would receive either a new acid blocker or a double dose of a standard acid reducer.
This study compares two medications—vonorasan and esomeprazole—to see which one heals stomach ulcers better after a specific type of endoscopic surgery. The goal is to find the safest and most effective way to help your ulcer recover.
This trial tests a newer medication called vonoprazan against the standard treatment pantoprazole for patients with gastroesophageal reflux disease (GERD). The goal is to see which one works better for controlling symptoms like heartburn and acid reflux over 8 weeks.
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
Hear when a new Erosive Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.